The procurement of dexamethasone sodium phosphate injection by Tianxin Company in Baiyun Mountain has passed the evaluation of consistency in quality and efficacy of generic drugs.

Recently, Baiyunshan Tianxin Company under the Guangzhou Pharmaceutical Group received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration. Dexamethasone Sodium Phosphate Injection has officially passed the generic drug quality and efficacy consistency evaluation. This product is mainly used for allergic and autoimmune inflammatory diseases, and for the comprehensive treatment of certain severe infections, poisoning, and malignant lymphoma. It is listed in the National Essential Medicines List and is a clinically essential medication.